MICHAEL GAJEWSKI: Open Payments
NPI 1629553755 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,478 in 259 payments from 22 companies in 2025. Trend: 2023 $2,663 · 2024 $8,699 · 2025 $50,478
Consulting: $24,400Travel & lodging: $10,270Speaker / faculty: $8,556Food & beverage: $7,252
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 90 | $35,620 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $4,679 |
| Lilly USA, LLC | 14 | $4,167 |
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $3,421 |
| AstraZeneca Pharmaceuticals LP | 16 | $482 |
| Abbott Laboratories | 19 | $446 |
| Alnylam Pharmaceuticals Inc. | 23 | $441 |
| BridgeBio Pharma, Inc. | 6 | $268 |
| E.R. Squibb & Sons, L.L.C. | 13 | $255 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $159 |
Products named: Barostim Neo System, JARDIANCE, Kerendia, ONPATTRO, CARDIOMEMS, Attruby, FARXIGA, LOKELMA.
Industry payments across SC — which companies pay providers there.
